Skip to main content

Table 7 Proportion of metastases by EAU risk groups (intermediate-risk vs high-risk group based on PSA and ISUP grade) (n = 189) on [18F]PSMA-1007 PET/CT

From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

  Intermediate-risk (PSA 10–20 ng/mL or ISUP 2 and 3) High-risk (PSA > 20 ng/mL or ISUP 4 and 5) p-value
  n = 71 n = 118  
SUVmax of primary tumoura 11.9 (8.4–21.1) 20.2 (12.0–32.5) < 0.001
Nodal metastasis(regional and non-regional)b 1.4% (1) 34.7% (41) < 0.001
Bone metastasisb 8.5% (6) 28.0% (33) 0.001
Visceral metastasisc 2.8% (2) 4.2% (5) 0.71
  1. aMann-Whitney U test
  2. bChi-squared test
  3. cFisher’s exact test; n = 2 with missing ISUP grade information and PSA < 20 ng/mL (undetermined risk group) and n = 3 with PSA < 10 and ISUP = 1(low risk) were excluded; % (n) = percentage of patients (number of patients)